BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11323756)

  • 1. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Takahashi RN; Berton O; Mormède P; Chaouloff F
    Braz J Med Biol Res; 2001 May; 34(5):675-82. PubMed ID: 11323756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP.
    Durand M; Mormède P; Chaouloff F
    Behav Pharmacol; 2003 Mar; 14(2):173-7. PubMed ID: 12658079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G; Perrault G; Sanger DJ
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central serotonergic systems in the spontaneously hypertensive and Lewis rat strains that differ in the elevated plus-maze test of anxiety.
    Kulikov A; Aguerre S; Berton O; Ramos A; Mormede P; Chaouloff F
    J Pharmacol Exp Ther; 1997 May; 281(2):775-84. PubMed ID: 9152385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.
    Kennett GA; Wood MD; Bright F; Cilia J; Piper DC; Gager T; Thomas D; Baxter GS; Forbes IT; Ham P; Blackburn TP
    Br J Pharmacol; 1996 Feb; 117(3):427-434. PubMed ID: 8821530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety.
    Martin JR; Ballard TM; Higgins GA
    Pharmacol Biochem Behav; 2002 Apr; 71(4):615-25. PubMed ID: 11888553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.
    Wood MD; Reavill C; Trail B; Wilson A; Stean T; Kennett GA; Lightowler S; Blackburn TP; Thomas D; Gager TL; Riley G; Holland V; Bromidge SM; Forbes IT; Middlemiss DN
    Neuropharmacology; 2001 Aug; 41(2):186-99. PubMed ID: 11489455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety.
    Nic Dhonnchadha BA; Bourin M; Hascoët M
    Behav Brain Res; 2003 Mar; 140(1-2):203-14. PubMed ID: 12644293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light/dark cycle manipulation influences mice behaviour in the elevated plus maze.
    Clénet F; Bouyon E; Hascoët M; Bourin M
    Behav Brain Res; 2006 Jan; 166(1):140-9. PubMed ID: 16165231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.
    Griebel G; Belzung C; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 2000 Feb; 148(2):164-70. PubMed ID: 10663431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze.
    Sakaue M; Ago Y; Sowa C; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2003 Jan; 458(1-2):141-4. PubMed ID: 12498918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.